Chen Yanni, Song Chenfei, Wang Jiaqin, Cao Yang, Lu Yueting, Han Xinmin
First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.
Shanghai Baoshan District Youyi Street Community Health Service Center, Shanghai, People's Republic of China.
J Asthma Allergy. 2025 May 6;18:705-721. doi: 10.2147/JAA.S512175. eCollection 2025.
Numerous studies have highlighted a link between COVID-19 and respiratory allergic conditions such as asthma and allergic rhinitis (AR). Despite the growing volume of research, there remains a notable gap in the form of a comprehensive bibliometric analysis that consolidates the findings on this association. This study aims to fill that gap by systematically exploring how asthma and AR interact with COVID-19.
By using the Web of Science Core Collection, we selected publications from January 2020 to October 2024 that related to COVID-19 and asthma/AR. Analysis tools such as VOSviewer and CiteSpace were employed to perform network mappings and citation analyses, focusing on co-authorship networks, keyword co-occurrences, and citation impacts to understand the research dynamics and collaborative patterns within this field.
A collection of 553 publications was obtained, revealing an upward trend in research volume over the study period. The United States, China, and the United Kingdom were predominant in the research output, demonstrating extensive international collaborations. The study highlighted key areas of impact, such as the influence of asthma types on COVID-19 severity and the protective effects of specific treatments like inhaled corticosteroids and biologics. Emerging trends identified included the significance of socioeconomic factors and obesity in disease outcomes, as well as evolving strategies in vaccination and interventions.
This bibliometric analysis highlights the significant role of global research in exploring the interactions between COVID-19 and asthma/AR. It points out the reported safety and effectiveness of COVID-19 vaccines for these conditions and acknowledges the challenges in vaccine uptake among minority and socioeconomically disadvantaged groups. The study also identifies unique risks for children and obese patients during the pandemic and underscores the need for increased international collaboration and more comprehensive clinical trials, to evaluate the efficacy of treatments like inhaled corticosteroids and biologics.
众多研究强调了新型冠状病毒肺炎（COVID-19）与哮喘和过敏性鼻炎（AR）等呼吸道过敏性疾病之间的联系。尽管研究数量不断增加，但在整合该关联研究结果的全面文献计量分析方面仍存在显著差距。本研究旨在通过系统探索哮喘和AR与COVID-19的相互作用来填补这一差距。
通过使用科学网核心合集，我们选取了2020年1月至2024年10月间与COVID-19和哮喘/AR相关的出版物。采用VOSviewer和CiteSpace等分析工具进行网络映射和引文分析，重点关注共同作者网络、关键词共现和引文影响，以了解该领域的研究动态和合作模式。
共获得553篇出版物，显示研究期间研究数量呈上升趋势。美国、中国和英国在研究产出方面占主导地位，表明存在广泛的国际合作。该研究突出了关键影响领域，如哮喘类型对COVID-19严重程度的影响以及吸入性糖皮质激素和生物制剂等特定治疗的保护作用。确定的新趋势包括社会经济因素和肥胖在疾病结局中的重要性，以及疫苗接种和干预措施的不断演变策略。
这项文献计量分析突出了全球研究在探索COVID-19与哮喘/AR之间相互作用方面的重要作用。它指出了COVID-19疫苗在这些疾病方面已报道的安全性和有效性，并认识到少数群体和社会经济弱势群体在疫苗接种方面面临的挑战。该研究还确定了疫情期间儿童和肥胖患者面临的独特风险，并强调需要加强国际合作和开展更全面的临床试验，以评估吸入性糖皮质激素和生物制剂等治疗方法的疗效。
